CA2479372A1 - Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof - Google Patents
Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof Download PDFInfo
- Publication number
- CA2479372A1 CA2479372A1 CA002479372A CA2479372A CA2479372A1 CA 2479372 A1 CA2479372 A1 CA 2479372A1 CA 002479372 A CA002479372 A CA 002479372A CA 2479372 A CA2479372 A CA 2479372A CA 2479372 A1 CA2479372 A1 CA 2479372A1
- Authority
- CA
- Canada
- Prior art keywords
- derivative
- glycoside
- apomorphine
- glycosidic
- orthoester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/18—Ring systems of four or more rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36545402P | 2002-03-19 | 2002-03-19 | |
| US60/365,454 | 2002-03-19 | ||
| PCT/US2003/008448 WO2003080074A1 (en) | 2002-03-19 | 2003-03-19 | Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2479372A1 true CA2479372A1 (en) | 2003-10-02 |
Family
ID=28454658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002479372A Abandoned CA2479372A1 (en) | 2002-03-19 | 2003-03-19 | Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060004190A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1496915A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2005526790A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20050008658A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1720054A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003223304A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0308567A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2479372A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003080074A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050090518A1 (en) * | 2003-10-24 | 2005-04-28 | Nastech Pharmaceutical Company Inc. | Method for treating parkinson's disease using apomorphine and apomorphine prodrugs |
| FR2939436B1 (fr) * | 2008-12-10 | 2010-12-17 | Sanofi Aventis | Synthese de morphine-6-glucuronide ou de l'un de ses derives |
| PT2952191T (pt) | 2009-06-12 | 2018-11-30 | Sunovion Pharmaceuticals Inc | Apomorfina sublingual |
| EP2651357B1 (en) | 2010-12-16 | 2020-04-01 | Sunovion Pharmaceuticals Inc. | Sublingual films |
| EP2854764B1 (en) | 2012-06-05 | 2018-12-12 | Neuroderm Ltd | Compositions comprising apomorphine and organic acids and uses thereof |
| KR20160108828A (ko) | 2013-11-11 | 2016-09-20 | 임팩스 라보라토리즈, 인코포레이티드 | 신속하게 붕괴되는 제형 및 사용 방법 |
| AU2015369554A1 (en) * | 2014-12-23 | 2017-08-03 | Neuroderm Ltd | Crystal forms of apomorphine and uses thereof |
| PT3713933T (pt) | 2017-11-24 | 2026-05-19 | H Lundbeck As | Novos profrmacos de catecolamina para utilizao no tratamento de doena de parkinson |
| US11104697B2 (en) | 2019-05-20 | 2021-08-31 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
| US11111263B2 (en) | 2019-05-20 | 2021-09-07 | H. Lundbeck A/S | Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
| US11130775B2 (en) | 2019-05-20 | 2021-09-28 | H. Lundbeck A/S | Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acid |
| US11168056B2 (en) | 2019-05-20 | 2021-11-09 | H. Lundbeck A/S | Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diol |
| EP3972600B1 (en) | 2019-05-21 | 2026-02-18 | H. Lundbeck A/S | Catecholamine carbamate prodrugs for use in the treatment of parkinson s disease |
| WO2020234275A1 (en) | 2019-05-21 | 2020-11-26 | H. Lundbeck A/S | New catecholamine prodrugs for use in the treatment of parkinson's diseases |
| US12391650B2 (en) | 2019-05-21 | 2025-08-19 | H. Lundbeck A/S | Catecholamine prodrugs for use in the treatment of Parkinson's disease |
| JP7641234B2 (ja) | 2019-05-21 | 2025-03-06 | ハー・ルンドベック・アクチエゼルスカベット | パーキンソン病の治療に使用するための新規なカテコールアミンプロドラッグ |
| CN114773409B (zh) * | 2022-04-27 | 2023-12-15 | 江西艾立斯特生物科技有限公司 | 一种2,3,4,6-四-o-乙酰基-吡喃葡萄糖的制备方法 |
| EP4540257A1 (en) | 2022-06-15 | 2025-04-23 | EVER Neuro Pharma GmbH | Apomorphine prodrugs and uses thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4785014A (en) * | 1985-06-07 | 1988-11-15 | Yale University | Use of clonidine in memory enhancement |
| DE69434304T2 (de) * | 1993-03-26 | 2005-12-29 | Merkus, Franciscus Wilhelmus H.M. | Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin |
| US6121276A (en) * | 1994-04-22 | 2000-09-19 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction |
| ATE312609T1 (de) * | 1994-04-22 | 2005-12-15 | Pentech Pharmaceuticals Inc | Sublinguale zusammensetzung enthaltend apomorphine zur diagnose der funktionellen impotenz |
| US5744476A (en) * | 1994-06-27 | 1998-04-28 | Interneuron Pharmaceuticals, Inc. | Dopamine D1 agonists for the treatment of dementia |
| US5562917A (en) * | 1994-12-23 | 1996-10-08 | Pentech Pharmaceuticals, Inc. | Transdermal administration of apomorphine |
| US5888534A (en) * | 1995-06-13 | 1999-03-30 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
| GB9517062D0 (en) * | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
| US5945117A (en) * | 1998-01-30 | 1999-08-31 | Pentech Pharmaceuticals, Inc. | Treatment of female sexual dysfunction |
| US6001845A (en) * | 1998-06-19 | 1999-12-14 | Schering Corporation | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction |
| US6011043A (en) * | 1998-06-19 | 2000-01-04 | Schering Corporation | Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction |
| US6266560B1 (en) * | 1998-06-19 | 2001-07-24 | Genetronics, Inc. | Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction |
| US5994363A (en) * | 1998-08-24 | 1999-11-30 | Pentech Pharmaceuticals, Inc. | Amelioration of apomorphine adverse effects |
| US6291471B1 (en) * | 1998-12-17 | 2001-09-18 | Abb Holdings, Inc. | Use of apomorphine for the treatment of organic erectile dysfunction in males |
| US6087362A (en) * | 1999-03-16 | 2000-07-11 | Pentech Pharmaceuticals, Inc. | Apomorphine and sildenafil composition |
| KR20030036157A (ko) * | 2000-04-07 | 2003-05-09 | 탭 파마슈티칼 프로덕츠 인코포레이티드 | 아포모르핀 유도체 및 이의 사용 방법 |
-
2003
- 2003-03-19 JP JP2003577900A patent/JP2005526790A/ja not_active Withdrawn
- 2003-03-19 US US10/508,160 patent/US20060004190A1/en not_active Abandoned
- 2003-03-19 BR BRPI0308567-8A patent/BR0308567A/pt not_active IP Right Cessation
- 2003-03-19 AU AU2003223304A patent/AU2003223304A1/en not_active Abandoned
- 2003-03-19 CN CNA038114879A patent/CN1720054A/zh active Pending
- 2003-03-19 CA CA002479372A patent/CA2479372A1/en not_active Abandoned
- 2003-03-19 EP EP03719419A patent/EP1496915A1/en not_active Withdrawn
- 2003-03-19 KR KR10-2004-7014649A patent/KR20050008658A/ko not_active Withdrawn
- 2003-03-19 WO PCT/US2003/008448 patent/WO2003080074A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1496915A1 (en) | 2005-01-19 |
| WO2003080074A1 (en) | 2003-10-02 |
| US20060004190A1 (en) | 2006-01-05 |
| JP2005526790A (ja) | 2005-09-08 |
| BR0308567A (pt) | 2007-01-09 |
| AU2003223304A1 (en) | 2003-10-08 |
| CN1720054A (zh) | 2006-01-11 |
| KR20050008658A (ko) | 2005-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20060004190A1 (en) | Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof | |
| KR100297862B1 (ko) | 선구약물 및 이의 제조방법 | |
| EP0618800B1 (en) | Glycosylated steroid derivatives for transport across biological membranes and process for making same | |
| CA2443774C (en) | Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation | |
| CN1964626A (zh) | 新型合成c-糖脂、其合成及其治疗传染病、癌症和自身免疫性疾病的用途 | |
| CN103702670A (zh) | 苷前体药物类似物的合成和应用 | |
| CN103781472B (zh) | 丙泊酚苷衍生物的合成和使用 | |
| US20050153928A1 (en) | Conjugates comprising a central nervous system-active drug linked to glucuronic acid or glucosamine through an amide bond and uses thereof | |
| JPH03118390A (ja) | エピポドフィロトキシン アルトロシド誘導体 | |
| US7217696B2 (en) | Glycuronamides, glycosides and orthoester glycosides of fluoxetine, analogs and uses thereof | |
| JPH10513485A (ja) | オピエート性物質の糖結合体 | |
| US6548485B2 (en) | Stable antitumor drug | |
| WO2002044191A2 (en) | Anti-inflammatory compounds derived from pseudopterogorgia elisabethae | |
| AU2002241521A1 (en) | Anti-inflammatory compounds derived from pseudopterogorgia elisabethae | |
| HK1084020A (en) | Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof | |
| WO1997013776A2 (fr) | Nouveaux derives amines de 2', 3' didesoxyglycosides d'epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux | |
| US20050107310A1 (en) | Carboxylic acid glycuronides, glycosamides and glycosides of quinolones, penicillins, analogs, and uses thereof | |
| JP7101279B2 (ja) | 新規なベンゾイミダゾール誘導体、この製造方法及び、これの抗がん剤の用途 | |
| KR100564383B1 (ko) | 진세노사이드 유도체의 제조방법 | |
| EP1438319A1 (en) | Derivatives of etoposide and analogs, and pharmaceutical compositions containing them | |
| EP4720196A1 (en) | Purpurin analogs for use in photodynamic therapy | |
| WO2001027129A1 (en) | Glycosides and orthoester glycosides of raloxifene and analogues and the use thereof | |
| KR0142228B1 (ko) | 신규 안트라사이클린 글리코시드유도체 및 그 제조방법 | |
| JPH0673084A (ja) | グリコシド及びこれを含有する抗肝炎剤 | |
| CA2746701A1 (fr) | Derives bicycliques de morphine-6-glucuronide, leur preparation et leur utilisation pour le traitement et la prevention de la douleur |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |